Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: andy71 who wrote (10959)	8/23/2018 11:24:50 AM
From: BoredMember	Read Replies (3) \| Respond to of 12871

No, it wasn’t set up knowing there would be a delay with tox. It was set up to never conduct tox. The BASi testing was done as a means of placating the angry investors who had had enough of the shenanigans with Dr. Anil Diwan laundering $5M in stock (and impacting the SP from which it had never recovered). So they did some small animal testing and then claimed they had to stop because it was so safe they needed way more testing material and couldn’t manufacture it. But that was 5(?) years ago and for a different indication. Ask yourself this: If they were that close with a treatment before, why scrap all that and start over for a treatment yet to be optimized and not yet licensed to Nanoviricides? Also ask why Dr. Boniuk and Dr. Eugene Seymour have left?